Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.

Literature DB >> 24812350

Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.

Robert D Simari¹, Carl J Pepine, Jay H Traverse, Timothy D Henry, Roberto Bolli, Daniel B Spoon, Ed Yeh, Joshua M Hare, Ivonne Hernandez Schulman, R David Anderson, Charles Lambert, Shelly L Sayre, Doris A Taylor, Ray F Ebert, Lemuel A Moyé.

Abstract

To understand the role of bone marrow mononuclear cells in the treatment of acute myocardial infarction, this overview offers a retrospective examination of strengths and limitations of 3 contemporaneous trials with attention to critical design features and provides an analysis of the combined data set and implications for future directions in cell therapy for acute myocardial infarction.

Entities: Chemical Disease Gene Species

Keywords: diagnostic imaging; myocardial infarction; population

Mesh：

Year: 2014 PMID： 24812350 PMCID： PMC4271539 DOI： 10.1161/CIRCRESAHA.114.303720

Source DB: PubMed Journal: Circ Res ISSN： 0009-7330 Impact factor: 17.367

26 in total

1. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors: Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal: Lancet Date: 2004 Jul 10-16 Impact factor: 79.321

2. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.

Authors: Young-sup Yoon; Andrea Wecker; Lindsay Heyd; Jong-Seon Park; Tengiz Tkebuchava; Kengo Kusano; Allison Hanley; Heather Scadova; Gangjian Qin; Dong-Hyun Cha; Kirby L Johnson; Ryuichi Aikawa; Takayuki Asahara; Douglas W Losordo
Journal: J Clin Invest Date: 2005-02 Impact factor: 14.808

3. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

Authors: Stefan Janssens; Christophe Dubois; Jan Bogaert; Koen Theunissen; Christophe Deroose; Walter Desmet; Maria Kalantzi; Lieven Herbots; Peter Sinnaeve; Joseph Dens; Johan Maertens; Frank Rademakers; Steven Dymarkowski; Olivier Gheysens; Johan Van Cleemput; Guy Bormans; Johan Nuyts; Ann Belmans; Luc Mortelmans; Marc Boogaerts; Frans Van de Werf
Journal: Lancet Date: 2006-01-14 Impact factor: 79.321

4. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Authors: Ketil Lunde; Svein Solheim; Svend Aakhus; Harald Arnesen; Michael Abdelnoor; Torstein Egeland; Knut Endresen; Arnfinn Ilebekk; Arild Mangschau; Jan G Fjeld; Hans Jørgen Smith; Eli Taraldsrud; Haakon Kiil Grøgaard; Reidar Bjørnerheim; Magne Brekke; Carl Müller; Einar Hopp; Asgrimur Ragnarsson; Jan E Brinchmann; Kolbjørn Forfang
Journal: N Engl J Med Date: 2006-09-21 Impact factor: 91.245

5. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors: Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal: N Engl J Med Date: 2006-09-21 Impact factor: 91.245

6. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Authors: Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Nikos Werner; Jürgen Haase; Jörg Neuzner; Alfried Germing; Bernd Mark; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal: Eur Heart J Date: 2006-11-10 Impact factor: 29.983

7. Bone marrow cells regenerate infarcted myocardium.

Authors: D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal: Nature Date: 2001-04-05 Impact factor: 49.962

Review 8. Cell-based therapy of myocardial infarction.

Authors: Stefanie Dimmeler; Jana Burchfield; Andreas M Zeiher
Journal: Arterioscler Thromb Vasc Biol Date: 2007-10-19 Impact factor: 8.311

9. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors: Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal: Nature Date: 2004-03-21 Impact factor: 49.962

10. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.

Authors: Leora B Balsam; Amy J Wagers; Julie L Christensen; Theo Kofidis; Irving L Weissman; Robert C Robbins
Journal: Nature Date: 2004-03-21 Impact factor: 49.962

24 in total

1. Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium.

Authors: Brian R Weil; Gen Suzuki; Merced M Leiker; James A Fallavollita; John M Canty
Journal: Circ Res Date: 2015-08-13 Impact factor: 17.367

2. Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014.

Authors: Patrick Celis; Nicolas Ferry; Marit Hystad; Martina Schüßler-Lenz; Pieter A Doevendans; Egbert Flory; Claire Beuneu; Ilona Reischl; Paula Salmikangas
Journal: Transfus Med Hemother Date: 2015-04-28 Impact factor: 3.747

Review 3. Vascular stem cells-potential for clinical application.

Authors: Sadie C Slater; Michele Carrabba; Paolo Madeddu
Journal: Br Med Bull Date: 2016-06 Impact factor: 4.291

4. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.

Authors: Jay H Traverse; Timothy D Henry; Carl J Pepine; James T Willerson; Atul Chugh; Phillip C Yang; David X M Zhao; Stephen G Ellis; John R Forder; Emerson C Perin; Marc S Penn; Antonis K Hatzopoulos; Jeffrey C Chambers; Kenneth W Baran; Ganesh Raveendran; Adrian P Gee; Doris A Taylor; Lem Moyé; Ray F Ebert; Robert D Simari
Journal: Circ Res Date: 2017-12-05 Impact factor: 17.367

5. Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies.

Authors: Mariann Gyöngyösi; Wojciech Wojakowski; Eliano P Navarese; Lemuel À Moye
Journal: Circ Res Date: 2016-04-15 Impact factor: 17.367